Price Chart

Price Chart

Profile

Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. It is developing the compound BIT225 for the treatment of HIV-1. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
URL http://www.biotron.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Core
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. It is developing the compound BIT225 for the treatment of HIV-1. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
URL http://www.biotron.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Core
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A